The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.

@article{Wright2001TheAA,
  title={The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.},
  author={Jackson T Jr Wright and William C. Cushman and Barry R. Davis and Jacob Barzilay and Pedro J. Colon and Debra A Egan and Tracy Lucente and Chuke E Nwachuku and Sara L. Pressel and Frans H.H. Leenen and Joseph P. Frolkis and Rebecca A Letterer and Steve Walsh and Jonathan N. Tobin and Grant E Deger},
  journal={Controlled clinical trials},
  year={2001},
  volume={22 6},
  pages={659-73}
}
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is a randomized clinical outcome trial of antihypertensive and lipid-lowering therapy in a diverse population (including substantial numbers of women and minorities) of 42,419 high-risk hypertensives aged > or = 55 years with a planned mean follow-up of 6 years. In this paper, we describe our experience in the identification, recruitment, and selection of clinical centers for this large simple trial capable… CONTINUE READING